Perspective · 5 Nov 2025
Research articlePublished 30 Jun 2022
Prevalence and Treatment Utilization of Patients Diagnosed with Depression and Anxiety Disorders Based on Kentucky Medicaid 2012-2019 Datasets
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Objectives: To examine the prevalence and treatment utilization of patients diagnosed with Depression and Anxiety Disorders (DAD) based on Kentucky Medicaid 2012-2019 datasets. Methods: The study was based on Kentucky Medicaid claims data from 2012 through 2019 for patients 14 years and older. We constructed yearly patient-level databases using ICD-9 CM and ICD-10 CM codes to identify the patients with DAD; the Current Procedure Terminology (CPT) codes to identify individual psychotherapy and group psychotherapy; and the National drug codes to categorize pharmacotherapy. Based on these data, we constructed summary tables that reflected the trends in prevalence of DAD across eight Kentucky Medicaid regions and for different demographic subgroups. Next, we implemented logistic regression on the constructed yearly patient-level data spanning all 8 years to formally assess the impact of risk factors and treatments on the occurrence of DAD. The potential risk factors included age, gender, race/ethnicity, geographic characteristics, comorbidities of alcohol use disorder and tobacco use. Results: The prevalence of DAD increased from 30.84% in 2012 to 36.04% in 2019. The prevalence of DAD was significantly higher in patients with the following characteristics: non-Hispanic white, females, aged between 45 and 54 years old, living in rural areas, having alcohol use disorder, and using tobaccos. Other than 2013, the utilization of pharmacotherapy maintained at about 62%. The utilization of psychotherapy increased over years from 24.4% in 2012 to 36.5% in 2019. Overall, utilization of any treatment slightly increased from 70.9% in 2012 to 73.3% in 2019 except a drastic decline in 2013 due to the reduction of Benzodiazepine prescription. Patients being whites, females, and living in rural areas were more likely to use pharmacotherapy, and patients living in rural areas were less likely to use psychotherapy than those residing in metro areas. Conclusion: The prevalence of DAD has increased over time from 2012 to 2019. The utilization of pharmacotherapy maintained at 62% over eight years except 2013, and the utilization of psychotherapy has steadily increased over time.
Subjects
Mental Health and PsychologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Depression and Anxiety.
Opinion · 5 Nov 2025
Protective Factors Promoting Resilience Against Depression and Anxiety
Perspective · 5 Nov 2025
Innovative Strategies for Effective Anxiety Management in Clinical Practice
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Depression and Anxiety
- SubjectMental Health and Psychology
- BylineArticles whose byline prints “Yuchen Han”
- BylineArticles whose byline prints “Haojiang Huang”
- BylineArticles whose byline prints “Riten Mitra”
- BylineArticles whose byline prints “Huirong Hu”
- BylineArticles whose byline prints “Subhadip Pal”
- BylineArticles whose byline prints “Craig McClain”
- BylineArticles whose byline prints “K.B. Kulasekera”
- BylineArticles whose byline prints “Maiying Kong”
